Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III, Multicentre, Randomized, Parallel Group, Double Blinded and Control Group Clinical Trial to Assess the Effectiveness of BioChaperone PDGF-BB In the Treatment of Chronic Diabetic Foot Ulcer

NCT02236793 is registered in ClinicalTrials.gov with Adocia as lead sponsor.

NCT NCT02236793
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02236793 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III, Multicentre, Randomized, Parallel Group, Double Blinded and Control Group Clinical Trial to Assess the Effectiveness of BioChaperone PDGF-BB In the Treatment of Chronic Diabetic Foot Ulcer
Lead sponsor
Adocia
Phase
Phase 3
Overall status
Completed
Start date
December 31, 2014
Completion date
August 31, 2016
Enrollment
252 (actual)
Sites
32

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic foot ulcer